ATP synthase modulation leads to an increase of spare respiratory capacity in HPV associated cancers.
Alphapapillomavirus
/ isolation & purification
Female
Humans
Mitochondrial Proton-Translocating ATPases
/ metabolism
Oncogene Proteins, Viral
/ metabolism
Oropharyngeal Neoplasms
/ virology
Oxidative Phosphorylation
Papillomavirus Infections
/ metabolism
Protein Binding
Squamous Cell Carcinoma of Head and Neck
/ virology
Survival Analysis
Tumor Virus Infections
/ metabolism
Journal
Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288
Informations de publication
Date de publication:
15 10 2020
15 10 2020
Historique:
received:
21
04
2020
accepted:
30
09
2020
entrez:
16
10
2020
pubmed:
17
10
2020
medline:
9
3
2021
Statut:
epublish
Résumé
Mucosal and skin cancers are associated with infections by human papillomaviruses (HPV). The manner how viral oncoproteins hijack the host cell metabolism to meet their own energy demands and how this may contribute to tumorigenesis is poorly understood. We now show that the HPV oncoprotein E7 of HPV8, HPV11 and HPV16 directly interact with the beta subunit of the mitochondrial ATP-synthase (ATP5B), which may therefore represent a conserved feature across different HPV genera. By measuring both glycolytic and mitochondrial activity we observed that the association of E7 with ATP5B was accompanied by reduction of glycolytic activity. Interestingly, there was a drastic increase in spare mitochondrial respiratory capacity in HPV8-E7 and an even more profound increase in HPV16-E7 expressing cells. In addition, we could show that ATP5B levels were unchanged in betaHPV positive skin cancers. However, comparing HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas (OPSCC) we noticed that, while ATP5B expression levels did not correlate with patient overall survival in HPV-negative OPSCC, there was a strong correlation within the HPV16-positive OPSCC patient group. These novel findings provide evidence that HPV targets the host cell energy metabolism important for viral life cycle and HPV-mediated tumorigenesis.
Identifiants
pubmed: 33060693
doi: 10.1038/s41598-020-74311-6
pii: 10.1038/s41598-020-74311-6
pmc: PMC7567072
doi:
Substances chimiques
Oncogene Proteins, Viral
0
Mitochondrial Proton-Translocating ATPases
EC 3.6.3.-
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
17339Références
Br J Cancer. 2017 Jun 6;116(12):1604-1611
pubmed: 28472822
Front Microbiol. 2018 May 02;9:874
pubmed: 29770129
Int J Cancer. 2015 Apr 1;136(7):1589-99
pubmed: 25104331
Cell Oncol. 2009;31(3):213-26
pubmed: 19478389
Nature. 2012 Jul 26;487(7408):491-5
pubmed: 22810586
Front Oncol. 2019 May 08;9:355
pubmed: 31134154
Am J Transplant. 2018 May;18(5):1220-1230
pubmed: 29024374
J Invest Dermatol. 2009 Apr;129(4):1026-34
pubmed: 18923444
Nat Cell Biol. 2017 Apr;19(4):318-328
pubmed: 28288130
Biomolecules. 2019 Aug 08;9(8):
pubmed: 31398842
J Virol. 2019 Dec 12;94(1):
pubmed: 31597772
Cancer Res. 2005 Mar 15;65(6):2216-23
pubmed: 15781634
Cancer Res. 2015 Sep 15;75(18):3685-6
pubmed: 26374463
Cancer Immunol Immunother. 2020 Jul;69(7):1363-1373
pubmed: 32232506
Viruses. 2017 Jul 14;9(7):
pubmed: 28708084
Curr Protoc Immunol. 2016 Apr 01;113:3.16B.1-3.16B.14
pubmed: 27038461
Methods Mol Med. 2005;114:257-68
pubmed: 16156109
Cell Death Differ. 2002 Jul;9(7):750-7
pubmed: 12058280
Cancer Prev Res (Phila). 2019 Jun;12(6):375-382
pubmed: 31003993
Mol Cell Biol. 2000 Feb;20(4):1436-47
pubmed: 10648628
J Clin Microbiol. 2006 Feb;44(2):504-12
pubmed: 16455905
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
J Virol. 2019 Mar 21;93(7):
pubmed: 30700603
J Gen Virol. 2016 Feb;97(2):463-472
pubmed: 26645068
J Virol. 2017 Mar 13;91(7):
pubmed: 28100625
Mol Cell Proteomics. 2015 Apr;14(4):1113-26
pubmed: 25670805
Int J Mol Sci. 2020 Jul 23;21(15):
pubmed: 32718057
Virus Res. 2020 Sep;286:198016
pubmed: 32445871
Curr Opin Virol. 2015 Oct;14:87-92
pubmed: 26398222
Cancers (Basel). 2019 Feb 05;11(2):
pubmed: 30764513
J Virol. 2013 Nov;87(22):12158-65
pubmed: 24006432
Pathogens. 2020 Feb 18;9(2):
pubmed: 32085533
Oncotarget. 2018 Sep 25;9(75):34142-34158
pubmed: 30344928
Am J Pathol. 2003 Mar;162(3):747-53
pubmed: 12598309
Radiat Res. 2015 Mar;183(3):291-304
pubmed: 25738895
Oncotarget. 2017 May 16;8(31):51530-51541
pubmed: 28881665
Oncotarget. 2016 Apr 19;7(16):21763-74
pubmed: 26943575
Proc Natl Acad Sci U S A. 2012 Jan 31;109(5):E260-7
pubmed: 22232672
BMC Cancer. 2019 May 31;19(1):531
pubmed: 31151416
Science. 1999 Nov 26;286(5445):1700-5
pubmed: 10576729
Oncotarget. 2015 Nov 3;6(34):36172-84
pubmed: 26452026
Int J Cancer. 2019 Aug 1;145(3):797-806
pubmed: 30786016
Oncogene. 2016 Aug 25;35(34):4529-39
pubmed: 26804167
Redox Biol. 2019 Jul;25:101076
pubmed: 30642723